Pointing out that riboflavin is a necessary coenzyme for glutathione reductase (one of a chain of enzymes which itself serves to maintain glutathione in the reduced form), they explained that though more research is needed it is likely that a riboflavin deficiency would impact glutathione function and may even impact the levels in the body. The researchers also suggested that vitamin B5 may support glutathione synthesis in the body due to its role in ATP production, while mentioning that vitamin B12 deficiency is linked with low glutathione levels
doi: 10.1016/j.jad.2022.07.015 81 KamalM
In recent years, several observational studies have suggested that GLP-1 drugs may be associated with lower risks for certain cancers or improved outcomes among cancer survivors
We postulated that a BETP-sensitized assay would prove effective for identifying weak agonists and were pleased to observe potentiation of GLP-1R-mediated cAMP signaling in response to the weak non-peptide GLP-1R agonist BOC5 ( 24 ) (Fig
At baseline, cardiovascular disease and risk factors were managed with lipid-lowering therapy (90%), platelet aggregation inhibitors (86%), angiotensin converting enzyme inhibitors or angiotensin II receptor blockers (74%), and beta blockers (70%)
Woo MS, Malsy J, Pttgen J, Seddiq Zai S, Ufer F, Hadjilaou A, et al